person reading

About Werewolf Therapeutics Inc - Company Information, Overview, History and Profile

What does Werewolf Therapeutics Inc do?

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Werewolf Therapeutics Inc Management structure

All Gross Remunerations are in USD
Mr. Timothy W. Trost
Chief Financial Officer, Principal Accounting Officer and Treasurer
-
2024
Gross Remuneration
Year
Dr. Daniel J. Hicklin,, PhD
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year

Werewolf Therapeutics Inc Board of directors

All Gross Remunerations are in USD
Dr. Derek DiRocco, PhD
Independent Director
-
2025
Gross Remuneration
Year
Dr. Anil K. Singhal, PhD
Director
-
2025
Gross Remuneration
Year